Eastern Maine Medical Center

Brewer, Maine 04412

1 studies enrolling now · 11 studies all time

What they study most

Breast Cancer, Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer, Multiple Myeloma, PD-L1 Negative, Prostate Cancer, Smoldering Multiple Myeloma, Smoldering Myeloma, Squamous Cell Carcinoma, Non-Small-Cell Lung, Triple Negative Breast Cancer

Studies at this site

• Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC — Recruiting now
• Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS) — Running, not enrolling
• A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer) — Running, not enrolling
• Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 — Running, not enrolling
• Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer — Stopped early
• Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma — Completed
• A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer — Completed
• Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma — Running, not enrolling
• E-PRISM: Phase II Trial of Elotuzumab Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma — Completed
• Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer — Completed
• Pilot Study for Young Women's Intervention — Completed